Blood Transfusion Devices Comprehensive Study by Type (Apheresis Systems, Infusion Devices, Blood Warmers, Venous Access Devices, Filters, Others), Application (Blood Disorders, Autoimmune Disorders, Cancer, Renal Disorders, Surgical Procedures, Others), End User (Hospitals, Ambulatory Surgery Centers, Dialysis Centers, Others) Players and Region - Global Market Outlook to 2026

Blood Transfusion Devices Market by XX Submarkets | Forecast Years 2022-2027  

  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Global Blood Transfusion Devices Market Overview:
Blood transfusion is refer as a medical procedure which involves the transferring blood products to the patients to replace the lost parts of the blood. The market of blood transfusion devices is expected to grow in the future due to a high prevalence disorders related to blood and also due to the rise in the incidence of chronic kidney disorders across the globe. Moreover, technological advancements in apheresis systems, blood warmers, infusion pumps, and transfusion filters have facilitated the availability of safe and highly purified blood to patients is boosting the market growth.

Growth Drivers
  • Increasing Number of Surgical Procedures
  • Rise in the Number of Blood Disorders

Roadblocks
  • Stringent Regulatory Framework

Opportunities
  • Increasing Infrastructure Developments in Developing Countries
  • Rising Healthcare Expenditures

Challenges
  • High Costs Associated with the Device


Competitive Landscape:
The Blood Transfusion Devices market is highly competitive and consists of several major players. However, with technological advancements and product innovation, mid-size to smaller companies are increasing their market presence by introducing new products with cost-effective pricing.
Some of the key players profiled in the report are Macopharma SA (France), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Abbott Laboratories (United States), Haemonetics Corporation (United States), Fresenius Kabi (Germany), Immucor Inc. (United States), Tenko Medical System Corp (United States), Grifols SA (Spain), Haemonetics Corporation (United States) and Armstrong Medical (United Kingdom). Analyst at AMA Research see United States Players to retain maximum share of Global Blood Transfusion Devices market by 2026. Considering Market by End User, the sub-segment i.e. Hospitals will boost the Blood Transfusion Devices market.

In May 2019, Ecomed Solutions has launched its HEMAsavR device for blood capture and transfer to help medical professionals reduce the costliness of allogeneic blood transfusions.

What Can be Explored with the Blood Transfusion Devices Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Blood Transfusion Devices Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Blood Transfusion Devices
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Blood Transfusion Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Blood Transfusion Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Blood Transfusion Devices Manufacturers, Blood Transfusion Devices Distributors/Traders/Wholesalers, Blood Transfusion Devices Subcomponent Manufacturers, Industry Association, Downstream Vendors, Medical Institutes, Government Regulatory Bodies, Government and Private Research Organizations and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Report Objectives / Segmentation Covered

By Type
  • Apheresis Systems
  • Infusion Devices
  • Blood Warmers
  • Venous Access Devices
  • Filters
  • Others
By Application
  • Blood Disorders
  • Autoimmune Disorders
  • Cancer
  • Renal Disorders
  • Surgical Procedures
  • Others
By End User
  • Hospitals
  • Ambulatory Surgery Centers
  • Dialysis Centers
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing Number of Surgical Procedures
      • 3.2.2. Rise in the Number of Blood Disorders
    • 3.3. Market Challenges
      • 3.3.1. High Costs Associated with the Device
    • 3.4. Market Trends
      • 3.4.1. Technological Advancements in the Devices
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Blood Transfusion Devices, by Type, Application, End User and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Blood Transfusion Devices (Value)
      • 5.2.1. Global Blood Transfusion Devices by: Type (Value)
        • 5.2.1.1. Apheresis Systems
        • 5.2.1.2. Infusion Devices
        • 5.2.1.3. Blood Warmers
        • 5.2.1.4. Venous Access Devices
        • 5.2.1.5. Filters
        • 5.2.1.6. Others
      • 5.2.2. Global Blood Transfusion Devices by: Application (Value)
        • 5.2.2.1. Blood Disorders
        • 5.2.2.2. Autoimmune Disorders
        • 5.2.2.3. Cancer
        • 5.2.2.4. Renal Disorders
        • 5.2.2.5. Surgical Procedures
        • 5.2.2.6. Others
      • 5.2.3. Global Blood Transfusion Devices by: End User (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Ambulatory Surgery Centers
        • 5.2.3.3. Dialysis Centers
        • 5.2.3.4. Others
      • 5.2.4. Global Blood Transfusion Devices Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Blood Transfusion Devices (Volume)
      • 5.3.1. Global Blood Transfusion Devices by: Type (Volume)
        • 5.3.1.1. Apheresis Systems
        • 5.3.1.2. Infusion Devices
        • 5.3.1.3. Blood Warmers
        • 5.3.1.4. Venous Access Devices
        • 5.3.1.5. Filters
        • 5.3.1.6. Others
      • 5.3.2. Global Blood Transfusion Devices by: Application (Volume)
        • 5.3.2.1. Blood Disorders
        • 5.3.2.2. Autoimmune Disorders
        • 5.3.2.3. Cancer
        • 5.3.2.4. Renal Disorders
        • 5.3.2.5. Surgical Procedures
        • 5.3.2.6. Others
      • 5.3.3. Global Blood Transfusion Devices by: End User (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Ambulatory Surgery Centers
        • 5.3.3.3. Dialysis Centers
        • 5.3.3.4. Others
      • 5.3.4. Global Blood Transfusion Devices Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Blood Transfusion Devices (Price)
      • 5.4.1. Global Blood Transfusion Devices by: Type (Price)
  • 6. Blood Transfusion Devices: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Macopharma SA (France)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Becton Dickinson (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. B. Braun Melsungen AG (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Terumo Corporation (Japan)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Abbott Laboratories (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Haemonetics Corporation (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Fresenius Kabi (Germany)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Immucor Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Tenko Medical System Corp (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Grifols SA (Spain)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Haemonetics Corporation (United States)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Armstrong Medical (United Kingdom)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Blood Transfusion Devices Sale, by Type, Application, End User and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Blood Transfusion Devices (Value)
      • 7.2.1. Global Blood Transfusion Devices by: Type (Value)
        • 7.2.1.1. Apheresis Systems
        • 7.2.1.2. Infusion Devices
        • 7.2.1.3. Blood Warmers
        • 7.2.1.4. Venous Access Devices
        • 7.2.1.5. Filters
        • 7.2.1.6. Others
      • 7.2.2. Global Blood Transfusion Devices by: Application (Value)
        • 7.2.2.1. Blood Disorders
        • 7.2.2.2. Autoimmune Disorders
        • 7.2.2.3. Cancer
        • 7.2.2.4. Renal Disorders
        • 7.2.2.5. Surgical Procedures
        • 7.2.2.6. Others
      • 7.2.3. Global Blood Transfusion Devices by: End User (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Ambulatory Surgery Centers
        • 7.2.3.3. Dialysis Centers
        • 7.2.3.4. Others
      • 7.2.4. Global Blood Transfusion Devices Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Blood Transfusion Devices (Volume)
      • 7.3.1. Global Blood Transfusion Devices by: Type (Volume)
        • 7.3.1.1. Apheresis Systems
        • 7.3.1.2. Infusion Devices
        • 7.3.1.3. Blood Warmers
        • 7.3.1.4. Venous Access Devices
        • 7.3.1.5. Filters
        • 7.3.1.6. Others
      • 7.3.2. Global Blood Transfusion Devices by: Application (Volume)
        • 7.3.2.1. Blood Disorders
        • 7.3.2.2. Autoimmune Disorders
        • 7.3.2.3. Cancer
        • 7.3.2.4. Renal Disorders
        • 7.3.2.5. Surgical Procedures
        • 7.3.2.6. Others
      • 7.3.3. Global Blood Transfusion Devices by: End User (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Ambulatory Surgery Centers
        • 7.3.3.3. Dialysis Centers
        • 7.3.3.4. Others
      • 7.3.4. Global Blood Transfusion Devices Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Blood Transfusion Devices (Price)
      • 7.4.1. Global Blood Transfusion Devices by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Blood Transfusion Devices: by Type(USD Million)
  • Table 2. Blood Transfusion Devices Apheresis Systems , by Region USD Million (2015-2020)
  • Table 3. Blood Transfusion Devices Infusion Devices , by Region USD Million (2015-2020)
  • Table 4. Blood Transfusion Devices Blood Warmers , by Region USD Million (2015-2020)
  • Table 5. Blood Transfusion Devices Venous Access Devices , by Region USD Million (2015-2020)
  • Table 6. Blood Transfusion Devices Filters , by Region USD Million (2015-2020)
  • Table 7. Blood Transfusion Devices Others , by Region USD Million (2015-2020)
  • Table 8. Blood Transfusion Devices: by Application(USD Million)
  • Table 9. Blood Transfusion Devices Blood Disorders , by Region USD Million (2015-2020)
  • Table 10. Blood Transfusion Devices Autoimmune Disorders , by Region USD Million (2015-2020)
  • Table 11. Blood Transfusion Devices Cancer , by Region USD Million (2015-2020)
  • Table 12. Blood Transfusion Devices Renal Disorders , by Region USD Million (2015-2020)
  • Table 13. Blood Transfusion Devices Surgical Procedures , by Region USD Million (2015-2020)
  • Table 14. Blood Transfusion Devices Others , by Region USD Million (2015-2020)
  • Table 15. Blood Transfusion Devices: by End User(USD Million)
  • Table 16. Blood Transfusion Devices Hospitals , by Region USD Million (2015-2020)
  • Table 17. Blood Transfusion Devices Ambulatory Surgery Centers , by Region USD Million (2015-2020)
  • Table 18. Blood Transfusion Devices Dialysis Centers , by Region USD Million (2015-2020)
  • Table 19. Blood Transfusion Devices Others , by Region USD Million (2015-2020)
  • Table 20. South America Blood Transfusion Devices, by Country USD Million (2015-2020)
  • Table 21. South America Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 22. South America Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 23. South America Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 24. Brazil Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 25. Brazil Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 26. Brazil Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 27. Argentina Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 28. Argentina Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 29. Argentina Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 30. Rest of South America Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 31. Rest of South America Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 32. Rest of South America Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 33. Asia Pacific Blood Transfusion Devices, by Country USD Million (2015-2020)
  • Table 34. Asia Pacific Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 35. Asia Pacific Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 36. Asia Pacific Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 37. China Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 38. China Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 39. China Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 40. Japan Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 41. Japan Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 42. Japan Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 43. India Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 44. India Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 45. India Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 46. South Korea Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 47. South Korea Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 48. South Korea Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 49. Taiwan Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 50. Taiwan Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 51. Taiwan Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 52. Australia Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 53. Australia Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 54. Australia Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 55. Rest of Asia-Pacific Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 56. Rest of Asia-Pacific Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 57. Rest of Asia-Pacific Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 58. Europe Blood Transfusion Devices, by Country USD Million (2015-2020)
  • Table 59. Europe Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 60. Europe Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 61. Europe Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 62. Germany Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 63. Germany Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 64. Germany Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 65. France Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 66. France Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 67. France Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 68. Italy Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 69. Italy Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 70. Italy Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 71. United Kingdom Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 72. United Kingdom Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 73. United Kingdom Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 74. Netherlands Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 75. Netherlands Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 76. Netherlands Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 77. Rest of Europe Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 78. Rest of Europe Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 79. Rest of Europe Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 80. MEA Blood Transfusion Devices, by Country USD Million (2015-2020)
  • Table 81. MEA Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 82. MEA Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 83. MEA Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 84. Middle East Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 85. Middle East Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 86. Middle East Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 87. Africa Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 88. Africa Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 89. Africa Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 90. North America Blood Transfusion Devices, by Country USD Million (2015-2020)
  • Table 91. North America Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 92. North America Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 93. North America Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 94. United States Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 95. United States Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 96. United States Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 97. Canada Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 98. Canada Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 99. Canada Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 100. Mexico Blood Transfusion Devices, by Type USD Million (2015-2020)
  • Table 101. Mexico Blood Transfusion Devices, by Application USD Million (2015-2020)
  • Table 102. Mexico Blood Transfusion Devices, by End User USD Million (2015-2020)
  • Table 103. Blood Transfusion Devices Sales: by Type(K Unit)
  • Table 104. Blood Transfusion Devices Sales Apheresis Systems , by Region K Unit (2015-2020)
  • Table 105. Blood Transfusion Devices Sales Infusion Devices , by Region K Unit (2015-2020)
  • Table 106. Blood Transfusion Devices Sales Blood Warmers , by Region K Unit (2015-2020)
  • Table 107. Blood Transfusion Devices Sales Venous Access Devices , by Region K Unit (2015-2020)
  • Table 108. Blood Transfusion Devices Sales Filters , by Region K Unit (2015-2020)
  • Table 109. Blood Transfusion Devices Sales Others , by Region K Unit (2015-2020)
  • Table 110. Blood Transfusion Devices Sales: by Application(K Unit)
  • Table 111. Blood Transfusion Devices Sales Blood Disorders , by Region K Unit (2015-2020)
  • Table 112. Blood Transfusion Devices Sales Autoimmune Disorders , by Region K Unit (2015-2020)
  • Table 113. Blood Transfusion Devices Sales Cancer , by Region K Unit (2015-2020)
  • Table 114. Blood Transfusion Devices Sales Renal Disorders , by Region K Unit (2015-2020)
  • Table 115. Blood Transfusion Devices Sales Surgical Procedures , by Region K Unit (2015-2020)
  • Table 116. Blood Transfusion Devices Sales Others , by Region K Unit (2015-2020)
  • Table 117. Blood Transfusion Devices Sales: by End User(K Unit)
  • Table 118. Blood Transfusion Devices Sales Hospitals , by Region K Unit (2015-2020)
  • Table 119. Blood Transfusion Devices Sales Ambulatory Surgery Centers , by Region K Unit (2015-2020)
  • Table 120. Blood Transfusion Devices Sales Dialysis Centers , by Region K Unit (2015-2020)
  • Table 121. Blood Transfusion Devices Sales Others , by Region K Unit (2015-2020)
  • Table 122. South America Blood Transfusion Devices Sales, by Country K Unit (2015-2020)
  • Table 123. South America Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 124. South America Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 125. South America Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 126. Brazil Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 127. Brazil Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 128. Brazil Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 129. Argentina Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 130. Argentina Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 131. Argentina Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 132. Rest of South America Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 133. Rest of South America Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 134. Rest of South America Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 135. Asia Pacific Blood Transfusion Devices Sales, by Country K Unit (2015-2020)
  • Table 136. Asia Pacific Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 137. Asia Pacific Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 138. Asia Pacific Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 139. China Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 140. China Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 141. China Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 142. Japan Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 143. Japan Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 144. Japan Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 145. India Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 146. India Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 147. India Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 148. South Korea Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 149. South Korea Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 150. South Korea Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 151. Taiwan Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 152. Taiwan Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 153. Taiwan Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 154. Australia Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 155. Australia Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 156. Australia Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 157. Rest of Asia-Pacific Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 158. Rest of Asia-Pacific Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 159. Rest of Asia-Pacific Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 160. Europe Blood Transfusion Devices Sales, by Country K Unit (2015-2020)
  • Table 161. Europe Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 162. Europe Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 163. Europe Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 164. Germany Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 165. Germany Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 166. Germany Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 167. France Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 168. France Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 169. France Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 170. Italy Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 171. Italy Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 172. Italy Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 173. United Kingdom Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 174. United Kingdom Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 175. United Kingdom Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 176. Netherlands Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 177. Netherlands Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 178. Netherlands Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 179. Rest of Europe Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 180. Rest of Europe Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 181. Rest of Europe Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 182. MEA Blood Transfusion Devices Sales, by Country K Unit (2015-2020)
  • Table 183. MEA Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 184. MEA Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 185. MEA Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 186. Middle East Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 187. Middle East Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 188. Middle East Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 189. Africa Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 190. Africa Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 191. Africa Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 192. North America Blood Transfusion Devices Sales, by Country K Unit (2015-2020)
  • Table 193. North America Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 194. North America Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 195. North America Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 196. United States Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 197. United States Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 198. United States Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 199. Canada Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 200. Canada Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 201. Canada Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 202. Mexico Blood Transfusion Devices Sales, by Type K Unit (2015-2020)
  • Table 203. Mexico Blood Transfusion Devices Sales, by Application K Unit (2015-2020)
  • Table 204. Mexico Blood Transfusion Devices Sales, by End User K Unit (2015-2020)
  • Table 205. Blood Transfusion Devices: by Type(USD/Units)
  • Table 206. Company Basic Information, Sales Area and Its Competitors
  • Table 207. Company Basic Information, Sales Area and Its Competitors
  • Table 208. Company Basic Information, Sales Area and Its Competitors
  • Table 209. Company Basic Information, Sales Area and Its Competitors
  • Table 210. Company Basic Information, Sales Area and Its Competitors
  • Table 211. Company Basic Information, Sales Area and Its Competitors
  • Table 212. Company Basic Information, Sales Area and Its Competitors
  • Table 213. Company Basic Information, Sales Area and Its Competitors
  • Table 214. Company Basic Information, Sales Area and Its Competitors
  • Table 215. Company Basic Information, Sales Area and Its Competitors
  • Table 216. Company Basic Information, Sales Area and Its Competitors
  • Table 217. Company Basic Information, Sales Area and Its Competitors
  • Table 218. Blood Transfusion Devices: by Type(USD Million)
  • Table 219. Blood Transfusion Devices Apheresis Systems , by Region USD Million (2021-2026)
  • Table 220. Blood Transfusion Devices Infusion Devices , by Region USD Million (2021-2026)
  • Table 221. Blood Transfusion Devices Blood Warmers , by Region USD Million (2021-2026)
  • Table 222. Blood Transfusion Devices Venous Access Devices , by Region USD Million (2021-2026)
  • Table 223. Blood Transfusion Devices Filters , by Region USD Million (2021-2026)
  • Table 224. Blood Transfusion Devices Others , by Region USD Million (2021-2026)
  • Table 225. Blood Transfusion Devices: by Application(USD Million)
  • Table 226. Blood Transfusion Devices Blood Disorders , by Region USD Million (2021-2026)
  • Table 227. Blood Transfusion Devices Autoimmune Disorders , by Region USD Million (2021-2026)
  • Table 228. Blood Transfusion Devices Cancer , by Region USD Million (2021-2026)
  • Table 229. Blood Transfusion Devices Renal Disorders , by Region USD Million (2021-2026)
  • Table 230. Blood Transfusion Devices Surgical Procedures , by Region USD Million (2021-2026)
  • Table 231. Blood Transfusion Devices Others , by Region USD Million (2021-2026)
  • Table 232. Blood Transfusion Devices: by End User(USD Million)
  • Table 233. Blood Transfusion Devices Hospitals , by Region USD Million (2021-2026)
  • Table 234. Blood Transfusion Devices Ambulatory Surgery Centers , by Region USD Million (2021-2026)
  • Table 235. Blood Transfusion Devices Dialysis Centers , by Region USD Million (2021-2026)
  • Table 236. Blood Transfusion Devices Others , by Region USD Million (2021-2026)
  • Table 237. South America Blood Transfusion Devices, by Country USD Million (2021-2026)
  • Table 238. South America Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 239. South America Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 240. South America Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 241. Brazil Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 242. Brazil Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 243. Brazil Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 244. Argentina Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 245. Argentina Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 246. Argentina Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 247. Rest of South America Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 248. Rest of South America Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 249. Rest of South America Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 250. Asia Pacific Blood Transfusion Devices, by Country USD Million (2021-2026)
  • Table 251. Asia Pacific Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 252. Asia Pacific Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 253. Asia Pacific Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 254. China Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 255. China Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 256. China Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 257. Japan Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 258. Japan Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 259. Japan Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 260. India Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 261. India Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 262. India Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 263. South Korea Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 264. South Korea Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 265. South Korea Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 266. Taiwan Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 267. Taiwan Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 268. Taiwan Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 269. Australia Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 270. Australia Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 271. Australia Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 272. Rest of Asia-Pacific Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 273. Rest of Asia-Pacific Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 274. Rest of Asia-Pacific Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 275. Europe Blood Transfusion Devices, by Country USD Million (2021-2026)
  • Table 276. Europe Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 277. Europe Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 278. Europe Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 279. Germany Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 280. Germany Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 281. Germany Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 282. France Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 283. France Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 284. France Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 285. Italy Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 286. Italy Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 287. Italy Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 288. United Kingdom Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 289. United Kingdom Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 290. United Kingdom Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 291. Netherlands Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 292. Netherlands Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 293. Netherlands Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 294. Rest of Europe Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 295. Rest of Europe Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 296. Rest of Europe Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 297. MEA Blood Transfusion Devices, by Country USD Million (2021-2026)
  • Table 298. MEA Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 299. MEA Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 300. MEA Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 301. Middle East Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 302. Middle East Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 303. Middle East Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 304. Africa Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 305. Africa Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 306. Africa Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 307. North America Blood Transfusion Devices, by Country USD Million (2021-2026)
  • Table 308. North America Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 309. North America Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 310. North America Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 311. United States Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 312. United States Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 313. United States Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 314. Canada Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 315. Canada Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 316. Canada Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 317. Mexico Blood Transfusion Devices, by Type USD Million (2021-2026)
  • Table 318. Mexico Blood Transfusion Devices, by Application USD Million (2021-2026)
  • Table 319. Mexico Blood Transfusion Devices, by End User USD Million (2021-2026)
  • Table 320. Blood Transfusion Devices Sales: by Type(K Unit)
  • Table 321. Blood Transfusion Devices Sales Apheresis Systems , by Region K Unit (2021-2026)
  • Table 322. Blood Transfusion Devices Sales Infusion Devices , by Region K Unit (2021-2026)
  • Table 323. Blood Transfusion Devices Sales Blood Warmers , by Region K Unit (2021-2026)
  • Table 324. Blood Transfusion Devices Sales Venous Access Devices , by Region K Unit (2021-2026)
  • Table 325. Blood Transfusion Devices Sales Filters , by Region K Unit (2021-2026)
  • Table 326. Blood Transfusion Devices Sales Others , by Region K Unit (2021-2026)
  • Table 327. Blood Transfusion Devices Sales: by Application(K Unit)
  • Table 328. Blood Transfusion Devices Sales Blood Disorders , by Region K Unit (2021-2026)
  • Table 329. Blood Transfusion Devices Sales Autoimmune Disorders , by Region K Unit (2021-2026)
  • Table 330. Blood Transfusion Devices Sales Cancer , by Region K Unit (2021-2026)
  • Table 331. Blood Transfusion Devices Sales Renal Disorders , by Region K Unit (2021-2026)
  • Table 332. Blood Transfusion Devices Sales Surgical Procedures , by Region K Unit (2021-2026)
  • Table 333. Blood Transfusion Devices Sales Others , by Region K Unit (2021-2026)
  • Table 334. Blood Transfusion Devices Sales: by End User(K Unit)
  • Table 335. Blood Transfusion Devices Sales Hospitals , by Region K Unit (2021-2026)
  • Table 336. Blood Transfusion Devices Sales Ambulatory Surgery Centers , by Region K Unit (2021-2026)
  • Table 337. Blood Transfusion Devices Sales Dialysis Centers , by Region K Unit (2021-2026)
  • Table 338. Blood Transfusion Devices Sales Others , by Region K Unit (2021-2026)
  • Table 339. South America Blood Transfusion Devices Sales, by Country K Unit (2021-2026)
  • Table 340. South America Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 341. South America Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 342. South America Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 343. Brazil Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 344. Brazil Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 345. Brazil Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 346. Argentina Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 347. Argentina Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 348. Argentina Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 349. Rest of South America Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 350. Rest of South America Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 351. Rest of South America Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 352. Asia Pacific Blood Transfusion Devices Sales, by Country K Unit (2021-2026)
  • Table 353. Asia Pacific Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 354. Asia Pacific Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 355. Asia Pacific Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 356. China Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 357. China Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 358. China Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 359. Japan Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 360. Japan Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 361. Japan Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 362. India Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 363. India Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 364. India Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 365. South Korea Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 366. South Korea Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 367. South Korea Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 368. Taiwan Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 369. Taiwan Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 370. Taiwan Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 371. Australia Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 372. Australia Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 373. Australia Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 374. Rest of Asia-Pacific Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 375. Rest of Asia-Pacific Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 376. Rest of Asia-Pacific Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 377. Europe Blood Transfusion Devices Sales, by Country K Unit (2021-2026)
  • Table 378. Europe Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 379. Europe Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 380. Europe Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 381. Germany Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 382. Germany Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 383. Germany Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 384. France Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 385. France Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 386. France Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 387. Italy Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 388. Italy Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 389. Italy Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 390. United Kingdom Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 391. United Kingdom Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 392. United Kingdom Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 393. Netherlands Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 394. Netherlands Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 395. Netherlands Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 396. Rest of Europe Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 397. Rest of Europe Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 398. Rest of Europe Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 399. MEA Blood Transfusion Devices Sales, by Country K Unit (2021-2026)
  • Table 400. MEA Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 401. MEA Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 402. MEA Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 403. Middle East Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 404. Middle East Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 405. Middle East Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 406. Africa Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 407. Africa Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 408. Africa Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 409. North America Blood Transfusion Devices Sales, by Country K Unit (2021-2026)
  • Table 410. North America Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 411. North America Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 412. North America Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 413. United States Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 414. United States Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 415. United States Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 416. Canada Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 417. Canada Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 418. Canada Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 419. Mexico Blood Transfusion Devices Sales, by Type K Unit (2021-2026)
  • Table 420. Mexico Blood Transfusion Devices Sales, by Application K Unit (2021-2026)
  • Table 421. Mexico Blood Transfusion Devices Sales, by End User K Unit (2021-2026)
  • Table 422. Blood Transfusion Devices: by Type(USD/Units)
  • Table 423. Research Programs/Design for This Report
  • Table 424. Key Data Information from Secondary Sources
  • Table 425. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Blood Transfusion Devices: by Type USD Million (2015-2020)
  • Figure 5. Global Blood Transfusion Devices: by Application USD Million (2015-2020)
  • Figure 6. Global Blood Transfusion Devices: by End User USD Million (2015-2020)
  • Figure 7. South America Blood Transfusion Devices Share (%), by Country
  • Figure 8. Asia Pacific Blood Transfusion Devices Share (%), by Country
  • Figure 9. Europe Blood Transfusion Devices Share (%), by Country
  • Figure 10. MEA Blood Transfusion Devices Share (%), by Country
  • Figure 11. North America Blood Transfusion Devices Share (%), by Country
  • Figure 12. Global Blood Transfusion Devices: by Type K Unit (2015-2020)
  • Figure 13. Global Blood Transfusion Devices: by Application K Unit (2015-2020)
  • Figure 14. Global Blood Transfusion Devices: by End User K Unit (2015-2020)
  • Figure 15. South America Blood Transfusion Devices Share (%), by Country
  • Figure 16. Asia Pacific Blood Transfusion Devices Share (%), by Country
  • Figure 17. Europe Blood Transfusion Devices Share (%), by Country
  • Figure 18. MEA Blood Transfusion Devices Share (%), by Country
  • Figure 19. North America Blood Transfusion Devices Share (%), by Country
  • Figure 20. Global Blood Transfusion Devices: by Type USD/Units (2015-2020)
  • Figure 21. Global Blood Transfusion Devices share by Players 2020 (%)
  • Figure 22. Global Blood Transfusion Devices share by Players (Top 3) 2020(%)
  • Figure 23. Global Blood Transfusion Devices share by Players (Top 5) 2020(%)
  • Figure 24. BCG Matrix for key Companies
  • Figure 25. Macopharma SA (France) Revenue, Net Income and Gross profit
  • Figure 26. Macopharma SA (France) Revenue: by Geography 2020
  • Figure 27. Becton Dickinson (United States) Revenue, Net Income and Gross profit
  • Figure 28. Becton Dickinson (United States) Revenue: by Geography 2020
  • Figure 29. B. Braun Melsungen AG (Germany) Revenue, Net Income and Gross profit
  • Figure 30. B. Braun Melsungen AG (Germany) Revenue: by Geography 2020
  • Figure 31. Terumo Corporation (Japan) Revenue, Net Income and Gross profit
  • Figure 32. Terumo Corporation (Japan) Revenue: by Geography 2020
  • Figure 33. Abbott Laboratories (United States) Revenue, Net Income and Gross profit
  • Figure 34. Abbott Laboratories (United States) Revenue: by Geography 2020
  • Figure 35. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 36. Haemonetics Corporation (United States) Revenue: by Geography 2020
  • Figure 37. Fresenius Kabi (Germany) Revenue, Net Income and Gross profit
  • Figure 38. Fresenius Kabi (Germany) Revenue: by Geography 2020
  • Figure 39. Immucor Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 40. Immucor Inc. (United States) Revenue: by Geography 2020
  • Figure 41. Tenko Medical System Corp (United States) Revenue, Net Income and Gross profit
  • Figure 42. Tenko Medical System Corp (United States) Revenue: by Geography 2020
  • Figure 43. Grifols SA (Spain) Revenue, Net Income and Gross profit
  • Figure 44. Grifols SA (Spain) Revenue: by Geography 2020
  • Figure 45. Haemonetics Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 46. Haemonetics Corporation (United States) Revenue: by Geography 2020
  • Figure 47. Armstrong Medical (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 48. Armstrong Medical (United Kingdom) Revenue: by Geography 2020
  • Figure 49. Global Blood Transfusion Devices: by Type USD Million (2021-2026)
  • Figure 50. Global Blood Transfusion Devices: by Application USD Million (2021-2026)
  • Figure 51. Global Blood Transfusion Devices: by End User USD Million (2021-2026)
  • Figure 52. South America Blood Transfusion Devices Share (%), by Country
  • Figure 53. Asia Pacific Blood Transfusion Devices Share (%), by Country
  • Figure 54. Europe Blood Transfusion Devices Share (%), by Country
  • Figure 55. MEA Blood Transfusion Devices Share (%), by Country
  • Figure 56. North America Blood Transfusion Devices Share (%), by Country
  • Figure 57. Global Blood Transfusion Devices: by Type K Unit (2021-2026)
  • Figure 58. Global Blood Transfusion Devices: by Application K Unit (2021-2026)
  • Figure 59. Global Blood Transfusion Devices: by End User K Unit (2021-2026)
  • Figure 60. South America Blood Transfusion Devices Share (%), by Country
  • Figure 61. Asia Pacific Blood Transfusion Devices Share (%), by Country
  • Figure 62. Europe Blood Transfusion Devices Share (%), by Country
  • Figure 63. MEA Blood Transfusion Devices Share (%), by Country
  • Figure 64. North America Blood Transfusion Devices Share (%), by Country
  • Figure 65. Global Blood Transfusion Devices: by Type USD/Units (2021-2026)
List of companies from research coverage that are profiled in the study
  • Macopharma SA (France)
  • Becton Dickinson (United States)
  • B. Braun Melsungen AG (Germany)
  • Terumo Corporation (Japan)
  • Abbott Laboratories (United States)
  • Haemonetics Corporation (United States)
  • Fresenius Kabi (Germany)
  • Immucor Inc. (United States)
  • Tenko Medical System Corp (United States)
  • Grifols SA (Spain)
  • Haemonetics Corporation (United States)
  • Armstrong Medical (United Kingdom)
Select User Access Type

Key Highlights of Report


Sep 2021 204 Pages 93 Tables Base Year: 2021 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The Blood Transfusion Devices market is expected to see a CAGR of % during projected year 2020 to 2026.
Top performing companies in the Global Blood Transfusion Devices market are Macopharma SA (France), Becton Dickinson (United States), B. Braun Melsungen AG (Germany), Terumo Corporation (Japan), Abbott Laboratories (United States), Haemonetics Corporation (United States), Fresenius Kabi (Germany), Immucor Inc. (United States), Tenko Medical System Corp (United States), Grifols SA (Spain), Haemonetics Corporation (United States) and Armstrong Medical (United Kingdom), to name a few.
"Technological Advancements in the Devices" is seen as one of major influencing trends for Blood Transfusion Devices Market during projected period 2020-2026.

Know More About Global Blood Transfusion Devices Report?